Lawmakers have just three weeks to work out a massive year-end spending package before government funding runs out Dec. 16, and the administration is facing resistance in its latest bid for additional COVID-19 funding. It also is unclear whether bipartisan measures to lower private insurer insulin prices, set up a new antibiotic reimbursement system and other drug-pricing-related riders might be slipped into a year-end deal. Meanwhile, the administration is racing to get more COVID-19 booster shots into arms while facing...